Profile
International Journal of Clinical Research & Trials Volume 5 (2020), Article ID 5:IJCRT-150, 3 pages
https://doi.org/10.15344/2456-8007/2020/150
Case Report
Valproic Acid Induced Pleural Effusion: A Rare Clinical and Pathophysiological Entity

Efthymia Papadopoulou1, Stavros Tryfon1,*, Maria Saroglou2, Dimitrios Vlachopoulos2, Athina Georgopoulou1 and Eva Serasli1

1Pulmonary Department of NHS, General Hospital “George Papanikolaou”, Thessaloniki, Greece
2Private Medicine, Thessaloniki, Greece
Dr. Stavros M. Tryfon, General Hospital “George Papanikolaou”, Thessaloniki, Greece, Tel: +30.6944597560, Fax: +30 2313 307286; E-mail: stavrostryfon@yahoo.gr
17 July 2020; 20 August 2020; 22 August 2020
Papadopoulou E, Tryfon S, Saroglou M, Vlachopoulos D, Georgopoulou A, et al. (2020) Valproic Acid Induced Pleural Effusion: A Rare Clinical and Pathophysiological Entity Int J Clin Res Trials 5: 150. doi: https://doi.org/10.15344/2456-8007/2020/150

References

  1. André S, Drowart A, De Bels D (2005) Lymphocytic pleural effusion associated with valproic acid. Eur J Intern Med 16: 535. [CrossRef] [Google Scholar] [PubMed]
  2. Tryfon S, Saroglou M, Kazanas K, Mermigkis C, Psathakis K, et al. (2009) Sodium valproate as a cause of recurrent transudative pleural effusion: a case report. J Med Case Reports 3: 51. [CrossRef] [Google Scholar] [PubMed]
  3. Bialer M (2012) Why are antiepileptic drugs used for nonepileptic conditions? Epilepsia 53: 26-33. [CrossRef] [Google Scholar] [PubMed]
  4. Aluisio AR, Zehtabchi S (2016) Valproate for Adult Migraine Prophylaxis. Am Fam Physician. [Google Scholar] [PubMed]
  5. Zhu MM, Li HL, Shi LH, Chen XP, Luo J, et al. (2017) The pharmacogenomics of valproic acid. J Hum Genet 62: 1009-1014. [Google Scholar]
  6. Vlahopoulos D, Saroglou M, Aggelis N, Kostakis E, Lykogiannis S, et al. (2015) Differences Between the Two Types of Pleural Effusion Related to Taking Valproic Acid; Unknown Origin Pleuritis Versus Drug Induced Lupus Pleural Effusion. Chest 148: 424A. [CrossRef] [Google Scholar]
  7. Alagha K, Tummino C, Sofalvi T, Chanez P (2011) Iatrogenic eosinophilic pleural effusion. Eur Respir Rev 20: 118-120. [CrossRef] [Google Scholar] [PubMed]
  8. Katayama H, Yokoyama A, Kohno N, Sakai K, Hiwada K, et al. (2002) Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol 26: 398-403. [CrossRef] [Google Scholar] [PubMed]
  9. Nakamura Y, Ozaki T, Kamei T, Kawaji K, Banno K, et al. (1993) Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol 8: 605-611. [CrossRef] [Google Scholar] [PubMed]
  10. Huggins JT, Sahn SA (2004) Drug-induced pleural disease. Clin Chest Med 25: 141-153. [CrossRef] [Google Scholar] [PubMed]
  11. Lacy M (2020) Eosinophilic pleural effusion: A case and a review. The Southwest Respiratory and Critical Care Chronicles 8: 40-46. [CrossRef] [Google Scholar]
  12. Karkhanis VS, Joshi JM (2012) Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med 4: 31-52. [CrossRef] [Google Scholar] [PubMed]